More reads
- FDA should disclose new drug agreements and response letters. (STAT)
- The future of Alzheimer’s treatment may be enlisting the immune system. (Medium)
- Macrogenics builds a case for margetuximab. (EP Vantage)
- Is China leapfrogging the world in applying AI to medicine? Here are five companies leading the charge. (STAT Plus)
No hay comentarios:
Publicar un comentario